Insider Buying and Selling - ACRV

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
08/25/2026	08/27/2026	Blume-Jensen Peter President and CEO CEO Director	Sell	-14,036 @ $2.21	($30,969.03)	2,230,052	(-0.63%)	Direct
08/18/2026	08/20/2026	Blume-Jensen Peter President and CEO CEO Director	Sell	-1,229 @ $2.01	($2,470.29)	2,244,088	(-0.05%)	Direct
08/18/2026	08/20/2026	Devroe Eric Chief Operating Officer Officer	Sell	-604 @ $2.01	($1,214.04)	146,349	(-0.41%)	Direct
08/18/2026	08/20/2026	Gamelin Erick Chief Development Officer Officer	Sell	-400 @ $2.01	($804.00)	52,592	(-0.75%)	Direct
08/18/2026	08/20/2026	Miller Mary Chief Legal Officer Officer	Sell	-185 @ $2.01	($371.85)	82,009	(-0.23%)	Direct
08/18/2026	08/20/2026	Peterson Katharine Chief Accounting Officer Officer	Sell	-101 @ $2.01	($203.01)	18,033	(-0.56%)	Direct
08/04/2026	08/06/2026	Levy Adam D. Chief Financial Officer CFO	Sell	-1,142 @ $1.57	($1,792.94)	66,008	(-1.70%)	Direct
07/21/2026	07/23/2026	Miller Mary Chief Legal Officer Officer	Sell	-573 @ $1.76	($1,008.48)	82,194	(-0.69%)	Direct
01/14/2026	01/16/2026	Blume-Jensen Peter President and CEO CEO Director	Buy	49,000 @ $1.68	$82,124.00	2,095,771	(2.39%)	Direct
01/14/2026	01/16/2026	Levy Adam D. Chief Financial Officer CFO	Buy	8,832 @ $1.70	$14,999.39	20,983	(72.69%)	Direct
01/13/2026	01/15/2026	Devroe Eric Chief Operating Officer Officer	Buy	10,000 @ $1.72	$17,218.00	75,308	(15.31%)	Direct

Acrivon Therapeutics, Inc. - ACRV